Improving Detection of Prediabetes in Children and Adults: Using Combinations of Blood Glucose Tests by Ike S. Okosun et al.
ORIGINAL RESEARCH
published: 20 November 2015
doi: 10.3389/fpubh.2015.00260
Edited by:
Ali Abbasi,
University of Cambridge School of
Clinical Medicine, UK
Reviewed by:
Melissa Irene March,
University Hospitals Case Medical
Center, USA
Julianne Toohey,
University of California Irvine, USA
*Correspondence:
Ike S. Okosun
iokosun@gsu.edu
Specialty section:
This article was submitted to
Diabetes, a section of the
journal Frontiers in Public Health
Received: 04 June 2015
Accepted: 04 November 2015
Published: 20 November 2015
Citation:
Okosun IS, Seale JP, Lyn R and
Davis-Smith YM (2015) Improving
Detection of Prediabetes in Children
and Adults: Using Combinations of
Blood Glucose Tests.
Front. Public Health 3:260.
doi: 10.3389/fpubh.2015.00260
Improving Detection of Prediabetes
in Children and Adults: Using
Combinations of Blood Glucose Tests
Ike S. Okosun1*, J. Paul Seale2, Rodney Lyn3 and Y. Monique Davis-Smith2
1 Division of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, GA, USA,
2 Department of Family Medicine, Mercer University School of Medicine, Macon, GA, USA, 3 Division of Health Management
and Policy, School of Public Health, Georgia State University, Atlanta, GA, USA
Highlights
 The combined use of fasting plasma glucose and hemoglobin A1c test is associated
with significantly higher diagnostic rates of prediabetes across age, race/ethnicity, and
BMI than using only one test.
 Combined use of fasting plasma glucose, hemoglobin A1c, and oral glucose tolerance
test do not improve the overall and gender-specific prediabetes prevalence beyond
what is observed using a combination fasting plasma glucose and hemoglobin A1c
test.
 A redefined hemoglobin A1c test that incorporates racial/ethnic, gender, age, and BMI
differences may provide a better way to use hemoglobin A1c test in population-based
and clinical settings.
Aim: To determine combinations of blood glucose tests: oral glucose tolerance (OGT),
fasting plasma glucose (FPG), and hemoglobin A1C (HbA1C) that are associated
with highest diagnostic rates of prediabetes in non-diabetic American children and
adults.
Methods: The 2007–2008 U.S. National Health and Nutrition Examination Surveys
data were used for this study. Overall and specific prevalence of prediabetes (defined
using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG, and OGT+ FPG+HbA1C tests) were
determined across age, race/ethnicity, sex, and BMI categories.
Results: FPG+HbA1C test was associated with significantly higher diagnostic rates of
prediabetes across age, race/ethnicity, and BMI. Estimates of overall prevalence of pre-
diabetes using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG, and OGT+ FPG+HbA1C
tests were 20.3, 24.2, 33, and 34.3%, respectively. Compared to OGT+ FPG, the
use of HbA1C+ FPG test in screening was associated with 44.8, 135, 38.6, and
35.9% increased prevalence of prediabetes in non-Hispanic White, non-Hispanic Black,
Mexican-American, and other racial/ethnic men, respectively. The corresponding values
in women were 67.8, 140, 37.2, and 42.6%, respectively. Combined use of all blood
glucose tests did not improve the overall and gender-specific prediabetes prevalence
beyond what was observed using HbA1C+ FPG test.
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Conclusion: HbA1C criteria were associated with higher diagnosis rates of prediabetes
than FPG and OGT tests in non-diabetic American children and adults. Using a combina-
tion of HbA1C and FPG test in screening for prediabetes reduces intrinsic systematic bias
in using just HbA1C testing and offers the benefits of each test. A well-defined HbA1C that
takes into consideration race/ethnicity, gender, age, and body mass index may improve
detection of prediabetes in population and clinical settings.
Keywords: glycated hemoglobin, glycemia, blood glucose tests, prediabetes
INTRODUCTION
Approximately, 24 million Americans are suffering from type
2 diabetes while more than 65 million others have prediabetes
(1, 2). The projected number of Americans with diagnosed type
2 diabetes is 39.0 million for 2050 (3), and a 100% increase
in prediabetes has been predicted for 2030 (1). Hence, accurate
identification of people with prediabetes is imperative before
applications of pharmacological and lifestyle interventions for the
prevention and delay of type 2 diabetes. The application of a
screening test that is both robust and handy is, therefore, vital
for promptly ascertaining subjects with prediabetes. A robust
and quick prediabetes diagnostic test can reduce overall societal
costs of diabetes by motivating subjects with prediabetes to seek
diabetes preventative care.
Fasting plasma glucose (FPG) and oral glucose tolerance
(OGT) tests are greatly used in screening and diagnosing type 2
diabetes. While the OGT test is mostly recognized as the bench-
mark for diagnosing type 2 diabetes, the test is laborious and
uncomfortable to patients. On the other hand, FPG is preferred
over OGT test since it is simple to conduct and the results are
highly reproducible. Applying FPG exclusive of OGT testing often
underestimates the prevalence of type 2 diabetes because the test
oftenmissmanypersonswhohave elevatedOGTaswell as normal
FPG (4). The American Diabetes Association (ADA) supports the
use of hemoglobin A1C (HbA1C) test in identifying subjects with
type 2 diabetes (5). ADA also advocates HbA1C test in identifying
at-risk persons and supports its use for establishing association
between elevated HbA1C andmicrovascular diseases (5). HbA1C
is an integrated measure of circulating glucose levels, providing
an overall appraisal of glucose level in the last 60–90 days, and is a
benchmark for prospective analysis of glycemic homeostasis (5).
Elevated HbA1C in non-diabetic adults is associated with
incident diabetes, cardiovascular disease morbidity and overall-
mortality (6–8). Unlike OGT, HbA1C test is quick and convenient
and can be completed any time notwithstanding duration of fast-
ing nor the type of priormeal. There are two important limitations
to the use HbA1C test in identifying subjects with type diabetes.
One, HbA1C test has good specificity for elevated glucose only
at HbA1C of 6.5% or greater (9, 10), and not very sensitive
at <6.5% levels. Lack of good sensitivity for blood glucose at
HbA1C of <6.5% may be due to inter-individual variations that
are related to red cell penetration, glycation, hemoglobin species,
vitamin and medication status, and red cell half-life, as well as
hyperglycemia (9–12). Two, there are important racial/ethnic dif-
ferences in HbA1C level. At any glycemic level, Blacks present
with much higher HbA1C values compared to Whites (13–18).
Hence, there is an ongoing debate on the appropriateness of using
the same HbA1C cutoff points in the diagnosis of type 2 diabetes
in Blacks and Whites (19, 20).
Thus far, there has been limited discussion regarding the accu-
racy of HbA1C test in diagnosing prediabetes. The aim of this
study is to determine combinations of blood glucose tests that
are associated with highest prevalence of prediabetes in American
children and adults. The result of this study will provide crucial
insight into how to improve detection of prediabetes giving its
increasing prevalence in children and adults. If specific population
groups can be identified in which accuracy of HbA1C test is
decreased, confirmatory testing with more accurate tests, such
as FPG and OGT tests, might be advantageous in identifying
individuals with truly impaired glucose tolerance (IGT) who are
at risk for future disease. We hypothesize that the combinations
of blood glucose tests that are associated with highest prevalence
of prediabetes will vary across age, gender, sex, race/ethnicity, and
BMI categories in American children and adults.
MATERIALS AND METHODS
Subjects and Study Design
The U.S. National Center for Health Statistics (NCHS) provided
the 2007–2008 National Health and Nutrition Examination Sur-
veys (NHANES) data that were utilized for this study. NHANES
are complex sampling designs that were administered to a rep-
resentative sample of U.S. non-institutionalized civilians. In the
surveys, study subjects were interviewed in their homes and lab-
oratory and physical examination were done in mobile exam-
ination centers for limited number of participants. The survey
plans have been described by other investigators (21, 22) and are
published in theWorldWideWeb (23). NCHS institutional review
board approved all NHANES study protocols. Informed consents
were obtained from all adult participants. For children who were
<18 years old children, informed consents were obtained from
their legal guardians.
For this study, only participants (ages 12–75 years) with no
missing values for age, height, weight, and assayed for OGT,
FPG andHbA1Cwere investigated. In NHANES, anthropometric
measures were obtained using established protocols (23). Height
was measured with a fixed stadiometer and weight was deter-
mined using a Toledo digital scale (Seritex, Carlstadt, NJ, USA).
BMI and race/ethnicity were also included among the variables
for this study. In NHANES, participants who were 12 years and
older were tested for abnormal blood glucose values using FPG,
OGT, and HbA1C tests (23).
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Definition of Terms
This study was restricted to non-diabetic children and adults
(ages 12–75 years). In this study, subjects were categorized as non-
diabetic if they had FPG of<125mg/dl or FPG of<199mg/dl on
a 2-h OGT test and HbA1C <6.5% (4, 5). Prediabetes comprises
impaired fasting glucose (IFG) expressed as FPG 100–125mg/dl,
IGT as OGT 140–199mg/dl, and HbA1C 5.7–6.4% (4, 5).
Two hundred and forty-two participants with history of dia-
betes and 57 pregnant women were disqualified in this anal-
ysis. Participants with congestive heart failure, coronary heart
disease, angina/angina pectoris, heart attack, and stroke were
also excluded in this study. We consider these diseases to be
associated with glycemia (24). Subjects who were eligible in
this study were not different from those who were excluded in
terms of age, gender, BMI, and race/ethnicity. In this study, four
racial/ethnic groups consisting of non-Hispanic Whites, non-
Hispanic Blacks, Mexican-Americans, and others (Hispanics and
multiracial groups) were used. BMI was categorized as low body
weight, healthy weight, overweight, class I obesity, class II obesity
and morbidly obese based on BMI of <20, 20–24.9, 25–29.9,
30–34.9, 35–39.9, and>40 kg/m2, respectively (25).
Statistical Analysis
SAS for Windows (SAS Release 9.1) was the statistical package
used in this analysis. To account for uneven sampling proba-
bilities, oversampling, and non-response, we used appropriate
sample weights for the analyses. We estimated SEs using the
SUDAAN statistical program (26). Racial/ethnic differences in
continuous variables, including age, anthropometric and glycemic
variables were determined with one-way analysis of variance
(ANOVA). Racial/ethnic and sex-differences in prevalence of
prediabetes using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG,
and OGT+ FPG+HbA1C tests were determined using the
χ2 tests. Pearson χ2 and Tukey’s post hoc tests were used
for pairwise comparisons for categorical and continuous vari-
ables, respectively. The relationships between HbA1C, OGT, and
FPG were determined using age and BMI adjusted Pearson’s
product-moment correlation coefficients. Prevalences of predia-
betes were determined using HbA1C, OGT, and FPG definitions
of prediabetes (4, 5).Overall and specific prevalence of prediabetes
(defined using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG, and
OGT+ FPG+HbA1C) were also determined across age, sex,
race/ethnicity, and BMI categories. In this investigation, P< 0.05
and 95% confidence intervals were computed andused to establish
statistical significance.
RESULTS
Characteristics of Studied Population
The basic anthropometric and clinical characteristics of non-
Hispanic Whites, non-Hispanic Blacks, Mexican-Americans,
and racial/ethnic groups that were eligible for this study are
shown in Table 1. There were racial/ethnic differences in age,
anthropometric, and glycemic variables. Non-Hispanic Whites
were older and taller than non-Hispanic Blacks, Mexican-
Americans and other racial/ethnic groups (P< 0.001). Defined
using BMI, non-Hispanic Blacks were heavier as compared to
non-Hispanic Whites and Mexican-Americans (P< 0.001). Non-
Hispanic Blacks also had higher values of HbA1C and lower
prevalence of OGT and FPG compared to non-Hispanic Whites
and Mexican-Americans (P< 0.01). The proportion of non-
Hispanic Blacks with HbA1C values of 5.7–6.4% was higher
than those of non-Hispanic Whites, Mexican-Americans and
Other racial/ethnic groups (P< 0.001). Fewer non-Hispanic
Blacks had IFG as compared with other racial/ethnic groups
(P< 0.001).
In Table 2, we compared trends in prevalence of prediabetes
as defined by HbA1C, FPG, and OGT across age and BMI cat-
egories. Overall, HbA1C test was associated with a much higher
prevalence of prediabetes in subjects who were over 50 years of
age and subjects who were obese compared to using FPG or OGT
test. Gradients of increasing prevalence of prediabetes from 12–19
to 70 years were observed for each blood glucose test (P< 0.01
for linear trend). Gradients of increasing prevalence of predia-
betes across BMI categories of <20, 20–24.9, 25–29.9, 30–34.9,
35–39.9, and >40 kg/m2, representing low body weight, healthy
weight, overweight, class I obesity, class II obesity and morbidly
obese were also determined. As shown, gradients of increasing
TABLE 1 | Anthropometric and clinical characteristics of studied populations of Americans who were eligible for this study.
Variables n Non-Hispanic White 2714 Non-Hispanic Black 1290 Mexican-American 1141 Others 1004 P-value
Age (years) 46:7a 0:41 38:7b 0:56 35:7c 0:53 39:9b 0:63 <0.001
Weight (kg) 78:5a 0:41 79:9a 0:63 74:2b 0:59 72:4b 0:62 <0.001
Height (cm) 169:2a 0:19 168:9a 0:27 162:5b 0:29 163:8c 0:32 <0.001
BMI (kg/m2) 27:3a 0:12 28:0b 0:21 28:0b 0:19 26:9a 0:21 <0.001
FPG (mg/dl) 99:3a 0:29 95:8b 0:42 100:1a 0:45 99:3a 0:47 <0.001
OGTTT (mg/dl) 111:5a 1:01 103:0b 1:50 111:9a 1:67 111:3a 1:71 <0.001
HbA1C (%) 5:40a 0:009 5:50b 0:018 5:41a 0:018 5:41b 0:019 <0.001
Prevalence of prediabetes (%)
OGT 7.3a 3.3b 6.6c 6.6c <0.001
FPG 19.8a 12.9b 16.0a 16.6a <0.001
HbA1C 20.0a 26.0b 20.0a 19.1c <0.001
a–cValues for continuous variables are in meansSEs.
BMI, body mass index; FPG, fasting plasma glucose values 100–125mg/dl; OGT, oral glucose tolerance test values 140–199mg/dl; HbA1C, hemoglobin A1c values 5.7–6.4%; pairwise
comparisons were done using, Tukey post hoc tests and chi-square tests for continuous and frequency variables, respectively, and values with different superscript differ at P< 0.05
levels; others, multiracial groups, and Hispanics.
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prevalence of prediabetes were evident using HbA1C, FPG, and
IGT tests (P< 0.01 for linear trend).
Correlation Between HbA1C, OGT, and
FPG in Non-Diabetic Children and Adults
We examined race/ethnic-specific correlation between HbA1C
and FPG, HbA1C and OGT, and FPG and OGT stratified by age
and BMI categories (Table 3). The greatest degrees of correlation
between HbA1C and FPG and between HbA1C and OGT were
observed among Mexican-Americans who were over 69 years of
age and with BMI of 40 or greater. A gradient of increasing corre-
lation between HbA1C and FPG with increasing age was evident
in the four racial/ethnic groups that were investigated, and ranged
TABLE 2 |Comparison of prevalence of prediabetes using HbA1C, FPG, and
OGT tests in non-diabetic American children and adults.
HbA1C FPG OGT P-value
Age category (%)
12–19 6:4 12:3 1:8 <0.001
20–29 5:8 12:3 2:2 <0.001
30–39 12:2 16:2 4:5 <0.001
40–49 21:2 20:3 7:9 <0.001
50–59 33:2 24:5 7:3 <0.001
60–69 38:1 24:4 10:2 <0.001
>70 38:8 23:2 12:9 <0.001
Test of linearity <0.001 <0.001 <0.001
BMI category (%)
<20 8:9 12:5 3:8 <0.001
20–24.9 14:8 15:5 4:2 <0.001
25–29.9 21:7a 21:8a 7:3 <0.001
30–34.9 29:6 21:7 9:7 <0.001
35–39.9 31:5 20:8 7:2 <0.001
>40 33:7 22:7 7:1 <0.001
Test of linearity <0.001 <0.001 <0.001
aValues with same superscript did not differ at <0.05 level.
FPG, fasting plasma glucose; HbA1C, hemoglobin A1C; OGT, oral glucose tolerance test.
TABLE 3 | Correlation between HbA1C and FPG, OGT and HbA1C, and OGT and FPG in non-diabetic American children and adults.
HbA1C and FPG OGT and HbA1C OGT and FPG
NHW NHB MA OR NHW NHB MA OR NHW NHB MA OR
Age category
12–19 0.251** 0.148 0.387** 0.293** 0.126 0.204 0.128 0.183 0.222* 0.377** 0.308** 0.133
20–29 0.207* 0.162 0.363** 0.392** 0.173 0.159 0.133 0.140 0.230* 0.301* 0.352** 0.251
30–39 0.330** 0.366** 0.169 0.293* 0.318* 0.050 0.275* 0.324* 0.472** 0.126 0.106 0.425**
40–49 0.214** 0.375** 0.236 0.329* 0.226** 0.054 0.063 0.076 0.424** 0.305* 0.043 0.328*
50–59 0.325** 0.377** 0.316* 0.249** 0.250** 0.137* 0.235** 0.210* 0.426** 0.188 0.178 0.334*
60–69 0.385* 0.427** 0.468** 0.456** 0.290** 0.210* 0.395** 0.324** 0.220* 0.255 0.223 0.020
>70 0.407** 0.463 0.612** 0.507** 0.334** 0.236** 0.606* 0.444** 0.246** 0.004 0.725* 0.398*
BMI category
<20 0.241* 0.183 0.230 0.376** 0.147 0.153 0.248 0.115 0.315** 0.302 0.124 0.071
20–24.9 0.315** 0.209** 0.283** 0.338** 0.262** 0.194* 0.222* 0.259* 0.396** 0.341** 0.175 0.384**
25–29.9 0.236** 0.227** 0.291* 0.350** 0.232** 0.224** 0.110 0.352** 0.403** 0.367** 0.330** 0.473**
30–34.9 0.290** 0.189* 0.336** 0.365** 0.357** 0.235* 0.249* 0.337** 0.423** 0.249* 0.091 0.337**
35–39.9 0.385** 0.346* 0.462** 0.347* 0.371** 0.287** 0.285* 0.348* 0.482** 0.534** 0.385* 0.584*
>40 0.605** 0.457* 0.467** 0.435** 0.394** 0.388* 0.398** 0.374** 0.200 0.016 0.535 0.018
NHW, non-Hispanic White; NHB, non-Hispanic Black; MA, Mexican-American; OR, other races; values are Pearson’s product-moment correlation coefficients.
FPG, fasting plasma glucose; HbA1C, hemoglobin A1C; OGT, oral glucose tolerance test.
*P<0.05; **P< 0.01.
from 0.251 to 0.407, 0.148 to 0.463, 0.387 to 0.612, and 0.293 to
0.507 in non-Hispanic Whites, non-Hispanic Blacks, Mexican-
Americans, and other races, respectively. A gradient of increasing
correlation between HbA1C and OGT with increasing age was
also evident in the four racial/ethnic groups that were investigated,
and ranged from 0.126 to 0.334, 0.204 to 0.236, 0.128 to 0.606,
and 0.183 to 0.444 in non-HispanicWhites, non-Hispanic Blacks,
Mexican-Americans, and other races, respectively.
A gradient of increasing correlation between HbA1C and FPG
with increasing BMIwas observed in the four racial/ethnic groups
that were investigated, and ranged from 0.241 to 0.605, 0.183
to 0.457, 0.230 to 0.467, and 0.376 to 0.435 in non-Hispanic
Whites, non-Hispanic Blacks, Mexican-Americans, and other
races, respectively. A gradient of increasing correlation between
HbA1C and OGT with increasing BMI was also seen in each
racial/ethnic group that was investigated, and ranged from 0.147
to 0.374, 0.153 to 0.338, 0.248 to 0.398, and 0.115 to 0.374 in non-
Hispanic White, non-Hispanic Black, Mexican-Americans, and
other races, respectively. For FPG and OGT, the highest degrees
of correlationwere found in non-HispanicWhites and other racial
groups who were 30 to 59 years old, and non-Hispanic Blacks and
Mexican-Americans who were 12–19 and over 70 years of age,
respectively.
Overall and Sex-Specific Prevalence of
Prediabetes in Non-Diabetic American
Children and Adults
Overall and sex-specific prevalences of prediabetes were
assessed using various combinations of blood glucose tests
that included OGT+ FPG, OGT+HbA1C, HbA1C+ FPG, and
OGT+ FPG+HbA1C. As shown in Figure 1, overall prevalences
of prediabetes were 20.3, 24.2, 33, and 34.3% using OGT+ FPG,
OGT+HbA1C, HbA1C+ FPG, and OGT+ FPG+HbA1C,
respectively. With the exception of OGT+HbA1C
determined prevalence of prediabetes, overall prevalences of
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FIGURE 1 | Overall and sex-specific prevalence of prediabetes in
non-diabetic American children and adults based on joint applications
of blood glucose tests.
prediabetes were higher in male participants compared with
females (P< 0.001). Results of comparative analysis indicated
no statistically significant differences in overall and sex-specific
prevalences that were determined using HbA1C+ FPG and
OGT+ FPG+HbA1C tests (P> 0.05).
Race/Ethnic and Sex-Specific Prevalence
of Prediabetes in Non-Diabetic American
Children and Adults
We compared prevalences of prediabetes using various
combinations of blood glucose tests across race/ethnicity
(Table 4). There were statistically significant racial/ethnic
differences in prevalence of prediabetes using OGT+ FPG,
OGT+HbA1C, HbA1C+ FPG, and OGT+ FPG+HbA1C
(P< 0.05). No statistically significant differences were observed
for the prevalence of prediabetes using HbA1C+ FPG and
OGT+ FPG+HbA1C tests. We compared prevalence of
prediabetes for the traditionally used OGT+ FPG test against
HbA1C+ FPG test. In men and women, HbA1C+ FPG test
resulted in a significantly higher prevalence of prediabetes
compared with OGT+ FPG test. In men, absolute differences
between prediabetes prevalences determined using OGT+ FPG
and HbA1C+ FPG tests were 11.6, 21.6, 9.5, and 8.4 in
non-Hispanic Whites, non-Hispanic Blacks, Mexican-
Americans and other racial/ethnic groups, respectively. The
corresponding values in women were 12.4, 17.8, 7.4, and 8.3,
respectively.
TABLE 4 | Race/ethnic-specific prevalence of prediabetes in non-diabetic
American children and adults.
Blood glucose tests Non-Hispanic
Whites
Non-Hispanic
Blacks
Mexican-
American
Others
Overall
OGT and FBG 21.8 14.3 22.3 21.4
OGT and HbA1C 24.5 27.4 21.1 22.8
HbA1C and FBG 34.0 33.7 30.8 31.8
OGT, FBG, and HbA1c 35.4 34.3 32.6 33.6
Male
OGT and FBG 25.9 16.0 24.6 23.4
OGT and HbA1C 23.6 30.6 19.7 22.8
HbA1C and FBG 37.5 37.0 34.1 31.8
OGT, FBG, and HbA1C 38.4 37.6 34.5 33.6
Female
OGT and FBG 18.3 12.7 19.9 19.5
OGT and HbA1C 25.5 24.2 22.6 22.2
HbA1C and FBG 30.7 30.5 27.3 27.8
OGT, FBG and HbA1C 32.4 31.0 30.7 30.3
Other races, Hispanics, and multiracial groups.
FPG, fasting plasma glucose; HbA1C, hemoglobin A1C; OGT, oral glucose tolerance test.
TABLE 5 | Age-specific prevalence of prediabetes in non-diabetic American
children and adults.
Blood glucose
tests
Age categories (years)
12–19 20–29 30–39 40–49 50–59 60–69 70+ Total
Overall
OGT and FBG 13.2 13.4 17.6 23.1 26.1 27.8 26.9 20.3
OGT and HbA1C 7.8 7.9 15.5 27.4 37.3 43.5 45.1 24.2
HbA1C and FBG 17.5 16.8 25.2 36.8 47.4 51.3 50.3 33.0
OGT, FBG, and
HbA1C
18.2 17.7 26.2 39.0 48.4 53.3 52.4 34.3
Male
OGT and FBG 17.5 17.7 20.1 23.8 28.7 29.9 29.2 23.0
OGT and HbA1C 9.2 9.4 16.5 30.2 37.3 38.7 48.4 24.3
HbA1c and FBG 2.5 23.4 30.6 42.3 50.7 49.0 51.4 36.5
OGT, FBG, and
HbA1C
23.2 23.6 30.8 42.8 51.0 50.4 53.7 32.3
Female
OGT and FBG 8.6 8.9 15.3 22.4 23.6 25.9 24.8 17.6
OGT and HbA1c 6.2 6.4 14.6 24.8 37.4 47.9 45.8 24.1
HbA1c and FBG 12.0 10.2 20.0 31.8 46.2 53.4 49.3 25.5
OGT, FBG, and
HbA1C
12.7 11.8 21.6 35.6 45.7 55.9 51.2 31.4
FPG, fasting plasma glucose; HbA1C, hemoglobin A1C; OGT, oral glucose tolerance test.
Age-Specific Prevalence of Prediabetes in
Non-Diabetic American Children and
Adults
In Table 5, we compared prevalences of prediabetes
using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG, and
OGT+ FPG+HbA1C tests across age categories of 12–19,
20–29, 30–39, 40–49, 50–59, 60–69, and >70. Overall, gradients
of increasing prevalences of prediabetes from 12–19 to >70 were
evident using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG,
and OGT+ FPG+HbA1C tests (P< 0.05 for linear trend). A
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gradient of increasing prevalence of prediabetes with increasing
age was also seen in both men and women using OGT+ FPG,
OGT+HbA1C, HbA1C+ FPG, andOGT+ FPG+HbA1C tests
(P< 0.05 for linear trend). Prevalences of prediabetes were higher
using HbA1C+ FPG test compared to using OGT+ FPG test in
every age group (P< 0.05). Prevalences of prediabetes were higher
in men irrespective of the combinations of blood glucose tests
that were used compared to women (P< 0.05). No statistically
significant differences in prevalences of prediabetes were found
using HbA1C+ FPG and OGT+ FPG+HbA1C tests. In men,
the highest absolute difference in prediabetes prevalence between
using HbA1C+ FPG test and OGT+ FPG test was 22.2 and
was recoded in the >70 age group. The corresponding value in
women was 27.5 and was observed in the 60–69-year-old group.
BMI-Specific Prevalence of Prediabetes in
Non-Diabetic American Children and
Adults
In Table 6, we compared prevalences of prediabetes across BMI
categories of <20, 20–24.9, 25–29.9, 30–34.9, 35–39.9, and >40,
representing low body weight, healthy weight, overweight, class I
obesity, class II obesity and morbidly obese, respectively. Over-
all, gradients of increasing prevalence of prediabetes from low
body weight to morbidly obese were evident using OGT+ FPG,
OGT+HbA1C, HbA1C+ FPG, andOGT+ FPG+HbA1C tests
(P< 0.05 for linear trend). A gradient of increasing prevalence of
prediabetes with increasing BMI was also found in both men and
women (P< 0.05 for linear trend). Results of comparative analysis
of prediabetes prevalence values indicated nodifferences in overall
and sex-specific prevalences at each level of BMI categories using
HbA1C+ FPG and OGT+ FPG+HbA1C tests (P> 0.05).
TABLE 6 | BMI-specific prevalence of prediabetes in non-diabetic American
children and adults.
Blood glucose
tests
Body mass index categories (kg/m2)
<20 20–24.9 25–29.9 30–34.9 35–39.9 40+ Total
Overall
OGT and FBG 14.5 17.4 23.9 24.5 22.2 23.9 21.1
OGT and HbA1C 11.6 17.7 26.1 35.3 36.5 36.9 25.2
HbA1C and FBG 19.8 26.4 36.9 43.5 44.4 46.3 34.3
OGT, FBG, and
HbA1C
21.4 27.9 38.3 45.0 45.6 47.1 35.8
Male
OGT and FBG 18.7 22.0 26.9 23.4 21.8 27.7 23.9
OGT and HbA1C 12.7 18.8 25.4 34.5 36.1 39.1 25.1
HbA1C and FBG 23.9 31.5 40.3 45.5 46.3 49.5 37.9
OGT, FBG, and
HbA1C
26.3 32.6 41.0 45.5 47.6 49.5 38.7
Female
OGT and FBG 11.0 13.0 20.4 25.6 22.4 21.4 18.4
OGT and HbA1C 10.7 16.7 27.0 36.1 36.8 35.1 25.2
HbA1c and FBG 16.3 21.4 32.8 41.5 43.4 44.2 30.9
OGT, FBG, and
HbA1C
17.3 23.2 35.0 44.4 44.5 45.5 32.8
FPG, fasting plasma glucose; HbA1C, hemoglobin A1C; OGT, oral glucose tolerance test.
DISCUSSION
While each of the blood glucose tests has its advantages, there is
no consensus on the best and the most appropriate blood glucose
test for screening for prediabetes in clinical and population-based
settings. In clinical practice, the OGT test is the gold standard
diagnostic test for type 2 diabetes. FPG testing alone lack enough
sensitivity to diagnose type 2 diabetes (4, 27). Indeed, diagnosis
of hyperglycemia using only FPG testing without including OGT
testing can lead to the omission of a large number of subjects with
normal FPG who have elevated OGT results. In population-based
settings, a screening test that lessens problems of OGT test may
yield a better prevalence estimate of prediabetes. HbA1C appears
to be a good test for improving the low yield associated with FPG
test while eliminating the need for fasting or waiting 2 h following
ingestion of a glucose load associated with OGT testing.
We argue that for community-based population screening,
HbA1C test is better than other blood glucose tests or at least
as good as both FPG and OGT tests for the reasons men-
tioned above. In the field, HbA1C test can be performed with
a point of care (POC) device that offers the following advan-
tages: study participants do not need to be fasting, testing is not
effected by content and timing of previous meals, and results are
immediately available. For both community-based research and
for community-based screening, this offers the opportunity for
immediate discussion and, if necessary, referral for further testing
and care if necessary. Indeed, in screening for prediabetes, HbA1C
test has been shown to be easier for patients and health providers
particularly during patient health care interactions regardless of
patient health conditions (28). Furthermore, HbA1C assay is an
excellent technique in identifying people who are at risk for
diabetes complications who could benefit from validated treat-
ments (9, 29). In addition, HbA1C is excellent for predicting
cardiovascular outcomes (8). Notwithstanding the advantages of
these blood glucose tests, screening for prediabetes using each
alone or using a combination of FPG and OGT often produces
dissimilar estimates (29, 30). Hence, it has been hinted that each
blood glucose test evaluates different domains of blood glucose
homeostasis (29, 31, 32). Indeed, damage in insulin secretion has
been found to be more germane in IFG, whereas unsteady insulin
sensitivity is exceptional to IGT (29, 31). Since no one blood
glucose test is able to identify all subjects with prediabetes, deter-
mining a combination of blood glucose tests that is associatedwith
identification of the greatest number of subjects with prediabetes
is critical for diabetes prevention programs (DPPs). To the best of
our knowledge, very few studies (32, 33) have examined whether
combined use of blood glucose tests in screening will enhance
detection of prediabetes in populations at risk for diabetes. There-
fore, this study was designed to determine the combination of
blood glucose tests that is associated with highest prevalence of
prediabetes across age, sex, race/ethnicity, and BMI categories.
In this study, correlation of HbA1C with FPG and OGT were
higher in Mexican-Americans who were 60 years old or greater
compared to other racial/ethnic groups. Additional studies are
needed to clarify reasons for the observed racial/ethnic differ-
ences in HbA1C values as well as the observed concordance
among blood glucose tests. In this study, ADA criteria for HbA1C
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resulted in much higher prevalences of undiagnosed prediabetes
than were estimated from FPG and OGT tests. Prevalences of
prediabetes using OGT tests were 7.3, 3.3, 6.6, and 6.7% in non-
Hispanic Whites, non-Hispanic Blacks, Mexican-Americans, and
other racial/ethnic groups, respectively. Prevalence values of pre-
diabetes using FPG tests were 19.8, 12.9, 16, and 16.6% in non-
Hispanic Whites, non-Hispanic Blacks, Mexican-Americans, and
other racial/ethnic groups, respectively. The corresponding values
using HbA1C tests were 20, 26, 20, and 19.1%, respectively.
Joint use of FPG and HbA1C test was associated with
significantly higher proportion of subjects with prediabetes
across age, race/ethnicity and BMI as compared to com-
bined use of OGT and FPG, OGT and HbA1C. Overall
prevalences of prediabetes using OGT+ FPG, OGT+HbA1C,
HbA1C+ FPG, and OGT+ FPG+HbA1C tests were 20.3, 24.2,
33, and 34.3%, respectively. This study indicates prediabetes
rates were higher using HbA1C+ FPG tests compared to the
traditionally used OGT+ FPG tests. Compared to OGT+ FPG
test, the use of HbA1C+ FPG test in screening was asso-
ciated with 44.8, 135, 38.6, and 35.9% increased prevalence
of prediabetes in non-Hispanic White, non-Hispanic Black,
Mexican-American, and other racial/ethnic men, respectively.
The analogous values in women were 67.8, 140, 37.2, and
42.6%, respectively. Overall, gradients of increasing prevalence
of prediabetes from 12–19 to 70 years and greater were evi-
dent using OGT+ FPG, OGT+HbA1C, HbA1C+ FPG, and
OGT+ FPG+HbA1C tests. In men and women, prevalences of
prediabetes were also found to increase linearly with increasing
BMI. Using all blood glucose tests (OGT+ FPG+HbA1C) did
not improve the overall and sex-specific prediabetes prevalence
beyond what was observed using HbA1C+ FPG test.
Our result, indicating higher prevalence of prediabetes using
FPG test compared with OGT test, is consistent with findings
by Unwin et al. (34) who compared glycemic criteria in three
ethnic groups in the UK. The results of this study, implying
differences in the prevalence of prediabetes using HbA1C, OGT,
and FPG, suggest that these blood glucose tests may be mea-
suring different aspects of blood glucose metabolism. The find-
ing of a far greater prevalence of prediabetes in non-Hispanic
Blacks using HbA1C criteria as compared with using OGT
and FPG tests is in agreement with findings from the DPP.
In DPP study, non-Hispanic Blacks with IGT were also found
with much elevated HbA1C levels compared to non-Hispanic
Whites, upon adjusting for glucose levels, age, sex, education,
blood pressure, BMI, hematocrit, and insulin resistance (16).
Our finding of greater prevalence of prediabetes in non-Hispanic
Blacks using HbA1C criteria as compared with using OGT and
FPG is unclear and may not be related to blood glucose con-
trol factors and our observed racial/ethnic differences in the
prevalence of prediabetes using HbA1C test may be associated
with to racial/ethnic differences in hemoglobin glycation or
red cell survival (11, 12). The reported within individual vari-
ation in HbA1C at the same levels of glycemia (11, 12, 16)
may be explained by racial/ethnic differences in red cell per-
meation, glycation, red cell half-life, vitamin and medication
use (11, 12).
The main strength of this report is in the use data from the
NHANES. NHANES represents one of the best available data
sources because it is a representative U.S. data. The measure-
ments and assays in NHANES were done using consistent tech-
niques. The training and quality control measures of NHANES
give added reliability to the data. However, the use of a single
determination of each of the blood glucose tests is a significant
limitation of this study. The use of a single glycemic measure is
often associated with overestimation of undiagnosed prediabetes
prevalence (12).
CONCLUSION
Using a combination of HbA1C and FPG test in screening for
prediabetes provides the benefits of individual test and decreases
the risk of systematic bias inherent in using only HbA1C testing.
This study proposes the need to redefine a basic and a practical
way on the application ofHbA1C in screening for prediabetes. The
use of HbA1C test in detection of prediabetes in population and
clinical settings should take into account patient race/ethnicity,
gender, age, and BMI.
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